Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 5, 2002, Pages 1481-1491

  Kim, Yun Kyung ^a   Pai, Hyunjoo ^a   Lee, Hoan Jong ^a   Park, Su Eun ^a   Choi, Eun Hwa ^a   Kim, Jungmin ^a   Kim, Je Hak ^a   Kim, Eui Chong ^a  

^a Seoul National University Children's Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE; CARBENICILLIN; CEFAZOLIN; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; IMIPENEM; NAFCILLIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; CHILD; DISEASE COURSE; DISEASE SEVERITY; ESCHERICHIA COLI; FATALITY; FEMALE; GENE SEQUENCE; HUMAN; INFANT; KLEBSIELLA PNEUMONIAE; LIGASE CHAIN REACTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; SURVIVAL;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 0036233003     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.5.1481-1491.2002     Document Type: Article

References (36)

1. A standard numbering scheme for the class A β-lactamases
2. Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia
3. Novel R-factor-borne β-lactamase conferring resistance to cephalosporins
4. Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases
5. Molecular epidemiology of plasmid spread among extended broad-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital
6. Nomenclature of TEM β-lactamases
7. Killing and regrowth of bacterial in vitro: A review
8. OXA-15, an extended-spectrum variant of OXA-2 β-lactamase, isolated from a Pseudomonas aeruginosa strain
9. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day
10. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A β-lactamase isolated from Escherichia coli
11. β-lactam antibiotic-induced release of free endotoxin: In vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime
12. Genetics of extended-spectrum β-lactamases
13. Deten of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli
14. More extended-spectrum β-lactamases
15. Extended broad spectrum β-lactamase conferring transferable resistance to newer β-lactam agents in enterobacteriaceae: Hospital prevalence and susceptibility patterns
16. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: Prevalence of SHV-12 and SHV-2a in Korea
17. Rapid discriminatory detection of genes coding for SHV β-lactamases by ligase chain reaction
18. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
19. PCR detection and identification of genes for extended-spectrum β-lactamases
20. The use of analytical isoelectric focusing for detection and identification of β-lactamases
21. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics
22. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins
23. Trends in β-lactam resistance among enterobacteriaceae
24. Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome
25. The characteristics of extended-spectrum P-lactamases in Korean isolates of enterobacteriaceae
26. Identification of CTX-M-14 extended-spectrum β-lactamase in clinical isolates of Shigella sonnei, Escherichia coli, and Klebsiella pneumoniae in Korea
27. The evolution of TEM-related extended-spectrum β-lactamases in Korea
28. Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates
29. Survey of extended-spectrum β-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: Prevalence of TEM-52 in Korea
30. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: Implication for the clinical microbiology laboratory
31. Extendedspectrum β-lactamases in Escherichia coli and Klebsiella spp. in European septicemia isolates
32. Molecular genetics of resistance to both ceftazidime and β-lactam-β-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to β-lactam therapy
33. Enterobacteriaceae: Introduction and identification
34. Ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae blood stream infection: A case-control and molecular epidemiologic investigation
35. Bacteremia due to extended-spectrum β-lactamaseproducing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: Clinical features and identification of differential plasmids carrying both SHV-5 and TEM-1 genes